Ergocalciferol ( DrugBank: Ergocalciferol )

5 diseases

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	2
84	Sarcoidosis	1
96	Crohn disease	1
97	Ulcerative colitis	1
299	Cystic fibrosis	1

46. Malignant rheumatoid arthritis

Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04472481 (ClinicalTrials.gov)	September 6, 2019	7/7/2020	Vitamin D Effect in Rheumatoid Arthritis.	Vitamin D: Does It Help Tregs in Active Rheumatoid Arthritis Patients.	Active Rheumatoid Arthritis	Drug: Ergocalciferol 1.25 mg tablet	Tanta University	NULL	Completed	33 Years	60 Years	All	20	Phase 4	Egypt
2	NCT01426347 (ClinicalTrials.gov)	January 2009	29/8/2011	Treatment of Vitamin D Deficiency in Patients With Rheumatoid Arthritis	Vitamin Therapy in Rheumatoid Arthritis	Rheumatoid Arthritis;Vitamin D Deficiency	Drug: Placebo sugar pill;Drug: Ergocalciferol	Johns Hopkins University	NULL	Completed	18 Years	75 Years	All	139	N/A	United States

Clinical trials : 149 / Drugs : 202 - (DrugBank : 78) / Drug target genes : 66 - Drug target pathways : 169

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03621553 (ClinicalTrials.gov)	July 1, 2010	17/7/2018	Vitamin D Homeostasis in Sarcoidosis	Vitamin D Homeostasis in Sarcoidosis	Sarcoidosis;Vitamin D Insufficiency	Drug: Ergocalciferol;Drug: Placebo;Drug: Calcium Citrate with Vitamin D2	University of Texas Southwestern Medical Center	NULL	Active, not recruiting	21 Years	N/A	All	90	Phase 4	United States

Clinical trials : 2,442 / Drugs : 1,278 - (DrugBank : 248) / Drug target genes : 142 - Drug target pathways : 209

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00621257 (ClinicalTrials.gov)	January 2008	11/2/2008	Vitamin D Levels in Children With IBD	Optimization of Vitamin D Stores and Its Impact on the Bone Health and Disease Outcomes of Children and Adolescents With IBD.	Inflammatory Bowel Disease;Crohn's Disease;Ulcerative Colitis	Dietary Supplement: ergocalciferol;Dietary Supplement: Cholecalciferol	Boston Children’s Hospital	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);Crohn's and Colitis Foundation;NASPGHAN Foundation	Terminated	5 Years	21 Years	All	134	N/A	United States

Clinical trials : 2,630 / Drugs : 1,459 - (DrugBank : 265) / Drug target genes : 144 - Drug target pathways : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00621257 (ClinicalTrials.gov)	January 2008	11/2/2008	Vitamin D Levels in Children With IBD	Optimization of Vitamin D Stores and Its Impact on the Bone Health and Disease Outcomes of Children and Adolescents With IBD.	Inflammatory Bowel Disease;Crohn's Disease;Ulcerative Colitis	Dietary Supplement: ergocalciferol;Dietary Supplement: Cholecalciferol	Boston Children’s Hospital	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);Crohn's and Colitis Foundation;NASPGHAN Foundation	Terminated	5 Years	21 Years	All	134	N/A	United States

Clinical trials : 1,695 / Drugs : 1,527 - (DrugBank : 268) / Drug target genes : 111 - Drug target pathways : 174

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00450073 (ClinicalTrials.gov)	November 2006	19/3/2007	Improving Vitamin D Status In Cystic Fibrosis	Desktop Tanning Unit to Improve Vitamin D Status in Patients With Cystic Fibrosis and Short Bowel Syndrome: A Pilot Study	Cystic Fibrosis	Drug: ergocalciferol (vitamin D2);Device: Sperti Del Sol Lamp;Drug: Vitamin D3	Atlanta VA Medical Center	Emory University	Completed	18 Years	60 Years	All	30	N/A	United States